Cost-effectiveness of pirfenidone for patients with cancer and grade 2 or grade 3 radiation-induced lung injury: A modeling study
Source: Plos.org· Qiu-Yi Pan, Ya-Xue Wang, Xue-Ying Tang, Zan Hou, Bai-Qiang Dong, Qi-Wen Li, Bao-Qing Chen, Shou-Min Bai, Chen-Fei Wu, Ming Chen· August 5, 2026
In this modelling study, Qiu-Yi Pan and colleagues provide a cost-effectiveness analysis of pirfenidone plus glucocorticoids versus glucocorticoids alone for the treatment of Grade 2 and Grade 3 Radiation-Induced Lung Injury in patients with cancer.
This story was reported by Plos.org. Read the full original article:
Read on Plos.org 
